iAB Financial Bank’s Novartis NVS Stock Holding History

iAB Financial Bank’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$674K	Sell	9,008 -205	-2%	-$14.5K	0.33%	71
2017 Q1	$613K	Sell	9,213 -558	-6%	-$37.2K	0.31%	70
2016 Q4	$638K	Sell	9,771 -390	-4%	-$25.3K	0.36%	63
2016 Q3	$719K	Sell	10,161 -329	-3%	-$24K	0.42%	54
2016 Q2	$776K	Buy	10,490 +502	+5%	+$34.7K	0.5%	49
2016 Q1	$648K	Sell	9,988 -112	-1%	-$7.62K	0.44%	52
2015 Q4	$779K	Sell	10,100 -558	-5%	-$44.3K	0.57%	41
2015 Q3	$878K	Sell	10,658 -1,395	-12%	-$124K	0.67%	38
2015 Q2	$1.06M	Hold	12,053	–	–	0.73%	35
2015 Q1	$1.06M	Buy	12,053 +1,228	+11%	+$109K	0.73%	33
2014 Q4	$899K	Sell	10,825 -112	-1%	-$9.28K	0.76%	35
2014 Q3	$922K	Sell	10,937 -390	-3%	-$31.6K	0.82%	35
2014 Q2	$919K	Sell	11,327 -112	-1%	-$8.81K	0.8%	36
2014 Q1	$871K	Buy	11,439 +167	+1%	+$12.2K	0.77%	34
2013 Q4	$812K	Sell	11,272 -781	-6%	-$54.3K	0.71%	38
2013 Q3	$828K	Sell	12,053 -669	-5%	-$44.3K	0.8%	33
2013 Q2	$806K	Buy	+12,722	New	+$828K	0.81%	35

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

iAB Financial Bank's NVS Position: Q2 2017 in Review

iAB Financial Bank reduced its Novartis (NVS) stake by 2.2% in Q2 2017, selling an estimated $14.5K and leaving 9,008 shares worth $674K. The position accounts for 0.33% of the portfolio, ranked #71.

iAB Financial Bank first reported a position in NVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.06M in Q1 2015. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

iAB Financial Bank held 9,008 shares of Novartis worth $674K as of Q2 2017.
iAB Financial Bank sold 205 Novartis shares in Q2 2017, an estimated $14.5K.
Novartis made up 0.33% of iAB Financial Bank's portfolio in Q2 2017, its #71 holding.
iAB Financial Bank first reported a position in Novartis in Q2 2013 and has held it in 17 quarters since.
iAB Financial Bank's Novartis position peaked at $1.06M in Q1 2015.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on iAB Financial Bank's 13F filing for Q2 2017, filed 4 Aug 2017.